RELIGARE ENT. has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Dec-17* | 3 Sep-18* | 3 Dec-18* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 78 | 13 | 8 | -40.4% | -90.1% |
Other income | Rs m | 1 | 101 | 115 | 12.8% | 8575.0% |
Turnover | Rs m | 80 | 115 | 122 | 6.8% | 53.5% |
Expenses | Rs m | 364 | 107 | 108 | 1.2% | -70.3% |
Gross profit | Rs m | -286 | -94 | -100 | ||
Depreciation | Rs m | 5 | 2 | 2 | -10.9% | -60.7% |
Interest | Rs m | 127 | 134 | 116 | -13.7% | -9.3% |
Profit before tax | Rs m | -417 | -128 | -103 | ||
Tax | Rs m | 0 | 0 | 0 | 0.0% | 0.0% |
Profit after tax | Rs m | -417 | -128 | -103 | ||
Gross profit margin | % | -364.5 | -716.2 | -1,285.9 | ||
Effective tax rate | % | 0.0 | 0.0 | 0.0 | ||
Net profit margin | % | -523.1 | -112.1 | -84.4 |
To see how RELIGARE ENT. has performed over the last eight quarters, please visit here.
Over the last one year, RELIGARE ENT. share price has moved up from Rs 54.4 to Rs 19.6, registering a Loss of Rs 34.8 or around 63.9%.
Overall, the S&P BSE SENSEX is up 6.0% over the year.
At the current price of Rs 19.6, the price to book value (P/BV) ratio of RELIGARE ENT. stands at 0.2 times.
| |
Here's an analysis of the annual report of RELIGARE ENT. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of RELIGARE ENT.. Also includes updates on the valuation of RELIGARE ENT..
For the quarter ended September 2018, RELIGARE ENT. has posted a net profit of Rs 128 m (up 57.9% YoY). Sales on the other hand came in at Rs 13 m (down 50.7% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.
For the quarter ended March 2018, RELIGARE ENT. has posted a net profit of Rs 643 m (up 27.2% YoY). Sales on the other hand came in at Rs 3 m (down 81.0% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.
Should you apply to the IPO of CreditAccess Grameen Ltd?
Should you subscribe to the IPO of HDFC AMC Ltd?
More Views on NewsWhat to do after every trade.
What we can learn from one of the greatest traders to have ever lived.
This corner of the market could provide more returns than blue chips in 2020.
Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.
2019 will be remembered as the year of great money-making IPOs...
More
| |
Equitymaster requests your view! Post a comment on "RELIGARE ENT. Announces Quarterly Results (3QFY19); Net Profit Up 75.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!